(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


10


Reuters

Latest News

CBC: 9 injured in apparent volcano eruption near Japan ski resort

ABC: Super Bowl brings Genie Bouchard and John Goehrke together again

Daily Mail: British lawyer's son at court for 'raping sleeping woman'

Daily Mail: Barnes leads Mavs past Wizards to snap skid

Daily Mail: Singer Neil Diamond diagnosed with Parkinson's disease,...

Daily Mail: Lisa Marie's estranged husband wants Presley to pay fees

Daily Mail: China criticizes Trump tariffs on solar, washing machines

Daily Mail: Mavs slow recent slide with season sweep of Wizards, 98-75

Daily Mail: Hyeon Chung v Tennys Sandgren match-up

CTV News: Massive fire at Port Coquitlam rail yard after fuel truck, train collide

CTV News: Evacuations ordered after fire breaks out at rail yard in Port Coquitlam, B.C.

Reuters: Mexico's Hoteles City Express to launch Fibra

AP: South Korea to start real-name trading of crypto currency

FOX: The Latest: Hundreds pack church, pray for girl who was shot

FOX: Rivendell Writers' Colony to close at the end of March

CBS: Pence says U.S. will move embassy to Jerusalem next year

ABC: China criticizes Trump tariffs on solar, washing machines

USA Today: Australian Open: Best of the quarterfinals

USA Today: Schroder scores 20 points, improving Hawks beat Jazz 104-90

USA Today: Varnado's putback lifts Troy over App State 81-79

ABC: South Korea to start real-name trading of crypto currency

Reuters: Tennis: Mertens stuns Svitolina to reach Melbourne semis

WashingtonPost: 9 injured in apparent volcano eruption near Japan ski resort